The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Clinical trial supply company strengthens its presence in the European Union
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.
100% efficacy against severe Covid-19 disease and hospitalizations
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Appoints Dr Rafiq Hasan as CEO
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
Subscribe To Our Newsletter & Stay Updated
